This role is responsible for the Clinical Safety strategy for assigned AstraZeneca-MedImmune drug projects and products throughout all stages of development and/or when on the market, including implementation and communication of the strategy at the project team/governance level. The position is also responsible for the continued safety assessment, evaluation, and risk management of AZ products or product groups in various stages of clinical development and/or the post-marketing setting. The role involves continuous efficient evaluation of adverse event and all other safety information to predict and manage the safety profile of compounds, identify needs for reference safety information updates, and drive proactive risk management initiatives in accordance with global regulatory requirements. It ensures consistent communication of safety topics across all regulatory safety documents (e.g., PBRERs, PADERs, DSURs) for assigned products/programs. The Medical Director proactively evaluates clinical implications of safety data from pre-clinical studies, clinical studies, literature, and other sources to establish the safety profile of compounds, utilizing expert groups and methodologies like Safety Knowledge Groups (SKG’s), Safety Science, Informatics expertise, modeling, and simulation to manage patient risk. The role requires collaborative work with experts across AZ-MedImmune and colleagues from Science Units as a leader/member of Safety Management Teams or other cross-functional project teams, promoting high-quality safety data evaluation. The individual will understand the QPPV role and contribute to pharmacovigilance system maintenance, and support key contacts with opinion leaders as needed.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees